Journal of Vascular Surgery
Volume 51, Issue 4, Supplement , Pages S4-S8 , April 2010

Uninsured South Florida vascular surgery patients are less likely to receive optimal medical management than their insured counterparts

Presented at the Twenty-second Annual Florida Vascular Society Scientific Session, Orlando, Florida, April 23-26, 2009, and at the Florida Chapter American College of Surgeons, Palm Coast, Florida, May 22-24, 2009.

Received 8 October 2009 ,Accepted 12 January 2010.

References 

  1. National Center for Health Statistics, Centers for Disease Control and Prevention. Compressed mortality file: underlying cause of death, 1979 to 2004. http://wonder.cdc.gov/cmf-icd9.htmlhttp://wonder.cdc.gov/cmf-icd10-archive2004.html.
  2. Centers for Medicare and Medicaid Services. Health care financing review: Medicare and Medicaid Statistical Supplement. http://www.cms.hhs.gov/MedicareMedicaidStatSupp/LT/list.asp?intNumPerPage=all&submit=Go
  3. Feinglass J, Pearce WH, Martin GF, Gibbs J, Cowper D, Sorensen M, et al. Postoperative and amputation-free survival outcomes after femorodistal bypass grafting surgery: findings from the Department of Veterans Affairs National Surgical Quality Improvement Program. J Vasc Surg. 2001;34:283–290
  4. Bainton D, Sainton P, Baker I, Elwood P. Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study. Br Heart J. 1994;72:128–132
  5. Timsit SG, Sacco RL, Mohr JP, Foulkes MA, Tatemichi TK, Wolf PA, et al. Early clinical differentiation of cerebral infarction from severe atherosclerotic stenosis and cardioembolism. Stroke. 1992;23:486–491
  6. Antiplatelet Trialists' Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J. 2002;524:71–86
  7. Pederson T, Kjekshus J, Berg K, Haghfelt T, Faergeman O, Faergeman G, et al. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383–1389
  8. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:45–53
  9. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med. 1998;339:489–497
  10. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood pressure-lowering drugs: results of prospectively designed overviews of randomized trials. Lancet. 2000;355:1955–1964
  11. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet. 2002;360:7–22
  12. Durazzo AE, Machado FS, Ikeoka DT, De Bernoche C, Monachini MC, Puech-Leao P, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg. 2004;39:967–976
  13. Pederson TR, Kjekshus J, Pyörälä K, Olsson AG, Cook TJ, Musliner TA, et al. Effect of simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Study (4S). Am J Cardiol. 1998;81:333–335
  14. Mondillo S, Ballo P, Barbati R, Guerrini F, Ammaturo T, Agricola E, et al. Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease. Am J Med. 2003;114:359–364
  15. Henke PK, Blackburn S, Proctor MC, Stevens J, Mukherjee D, Rajagopalin S, et al. Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: Effect on graft patency, limb salvage, and mortality. J Vasc Surg. 2004;39:357–365
  16. Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke. 1996;27:63–68
  17. Wolf PA, D'Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke: the Framingham Study. JAMA. 1988;259:1025–1029
  18. Smith SC, Blair SN, Bonow RO, Brass LM, Cerqueira MD, Dracup K, et al. AHA/ACC scientific statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. Circulation. 2001;104:1577–1579
  19. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317–1324
  20. Smith SC, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;113:2363–2372
  21. Kinikini D, Sarfati MR, Mueller MT, Kraiss LW. Meeting AHA/ACC secondary prevention goals in a vascular surgery practice: an opportunity we cannot afford to miss. J Vasc Surg. 2006;339:781–787
  22. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957–1963
  23. Betancourt M, Van Stavern RB, Share D, Gardella P, Martus M, Chaturvedi S. Are patients receiving maximal medical therapy following carotid endarterectomy?. Neurology. 2004;63:2011–2015
  24. Mukherjee D, Lingam P, Chetcuti S, Grossman PM, Moscucci M, Luciano AE, et al. Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions. Circulation. 2002;106:1909–1912
  25. McDermott MM, Mehta S, Ahn H, Greenland P. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med. 1997;12:209–215
  26. Burns P, Lima E, Bradbury AW. Second best medical therapy. Eur J Vasc Endovasc Surg. 2002;24:400–404
  27. Rehring TF, Sandhoff BG, Stolcpart RS, Merenich JA, Hollis HW. Atherosclerotic risk factor control in patients with peripheral arterial disease. J Vasc Surg. 2005;41:816–822
  28. Cassar K, Coull R, Bachoo P, Macaulay E, Brittenden J. Management of secondary risk factors in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 2003;26:262–266
  29. Ness J, Aronow WS, Newkirk E, McDanel D. Prevalence of symptomatic peripheral arterial disease, modifiable risk factors, and appropriate use of drugs in the treatment of peripheral arterial disease in older persons seen in a university general medicine clinic. J Gerontol. 2005;60A:255–257
  30. Bismuth J, Klitfod , Sillesen H. The lack of cardiovascular risk factor management in patients with critical limb ischemia. Eur J Vasc Endovasc Surg. 2001;21:143–146
  31. Stockwell DH, Madhavan S, Cohen H, Gibson G, Alderman MH. The determinants of hypertension awareness, treatment, and control in an insured population. Am J Public Health. 1994;84:1768–1774
  32. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2007;CD000031
  33. Law M, Tang JL. An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Intern Med. 1995;155:1933–1941
  34. Rask KJ, Williams MV, Parker RM, McNagny SE. Obstacles predicting lack of a regular provider and delays in seeking care for patients at an urban public hospital. JAMA. 1994;271:1931–1933
  35. Ahluwalia JS, McNagny SE, Rask KJ. Correlates of controlled hypertension in indigent, inner-city hypertensive patients. J Gen Intern Med. 1997;12:7–14
  36. Shulman NB, Martinez B, Brogan D, Carr AA, Miles CD. Financial cost as an obstacle to hypertnesion therapy. Am J Public Health. 1986;76:1105–1108
  37. González-Fernández RA, Rivera M, Torres D, Quiles J, Jackson A. Usefulness of a systemic hypertension in-hospital education program. Am J Cardiol. 1990;65:1384–1386
  38. Farquhar JW, Fortmann SP, Flora JA, Taylor CB, Haskell WL, William PT, et al. Effects of communitywide education on cardiovascular disease risk factors (The Stanford Five-City Project). JAMA. 1990;264:359–365
  39. Brook RH, Ware JE, Rogers WH, Keeler EB, Davies AR, Donald CA, et al. Does free care improve adults' health? (Results from a randomized controlled trial). N Engl J Med. 1983;309:1426–1434
  40. Keeler EB, Brook RH, Goldberg GA, Kamberg CJ, Newhouse JP. How free care reduced hypertension in the health insurance experiment. JAMA. 1985;254:1926–1931

 Competition of interest: none.

 The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.

PII: S0741-5214(10)00121-7

doi: 10.1016/j.jvs.2010.01.035

Journal of Vascular Surgery
Volume 51, Issue 4, Supplement , Pages S4-S8 , April 2010

Article Tools

* Image Usage & Resolution